News
Investors in Regeneron Pharmaceuticals, Inc. (Symbol: REGN) saw new options become available today, for the July 18th expiration. One of the key data points that goes into the price an option ...
Shares of biotech company Regeneron (NASDAQ:REGN) fell 9.6% in the morning session after the company reported weak first-quarter 2025 results. Its revenue missed significantly, and its EPS fell ...
Biotech company Regeneron (NASDAQ:REGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.7% year on year to $3.03 billion. Its non-GAAP profit of $8.22 per share was ...
Investors in Regeneron Pharmaceuticals, Inc. (Symbol: REGN) saw new options become available today, for the June 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...
Hosted on MSN22d
Regeneron to Report Q1 Earnings: What's in Store for the Stock?Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The Zacks Consensus Estimate for revenues is pegged at $3.25 billion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback